Bank of New York Mellon’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Hold
0
-$4.04K 4223
2023
Q4
Hold
0
4292
2023
Q3
Hold
0
4316
2023
Q2
Hold
0
4307
2023
Q1
Hold
0
4328
2022
Q4
Hold
0
4325
2022
Q3
Hold
0
4419
2022
Q2
Hold
0
4476
2022
Q1
Hold
0
4547
2021
Q4
Hold
0
4571
2021
Q3
Hold
0
4436
2021
Q2
Sell
-2
Closed -$328K 4276
2021
Q1
$338K Hold
2
﹤0.01% 3860
2020
Q4
$376K Hold
2
﹤0.01% 3743
2020
Q3
$238K Hold
2
﹤0.01% 3787
2020
Q2
$278K Buy
2
+1
+100% +$122K ﹤0.01% 3710
2020
Q1
$60K Buy
+1
New +$103K ﹤0.01% 3945

Other funds holding GNPX

Bank of New York Mellon's GNPX Position: Q1 2024 in Review

Bank of New York Mellon held its Genprex (GNPX) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4223.

Bank of New York Mellon first reported a position in GNPX in Q1 2020 and has held it in 5 quarters since. The position peaked at $376K in Q4 2020. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • Bank of New York Mellon held 0 shares of Genprex worth $0 as of Q1 2024.
  • Bank of New York Mellon left its Genprex share count unchanged in Q1 2024.
  • Genprex made up ﹤0.01% of Bank of New York Mellon's portfolio in Q1 2024, its #4223 holding.
  • Bank of New York Mellon first reported a position in Genprex in Q1 2020 and has held it in 5 quarters since.
  • Bank of New York Mellon's Genprex position peaked at $376K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.